More than one-in-four employers tightened utilization controls this year, or plan to in 2027, Mercer said
Follow-up Re-check metabolic markers and IGF-1 after 6-8 weeks, with earlier review if GI symptoms, glucose symptoms, or fluid retention occur
Developed exclusively for laboratory research, this multi-peptide formulation is designed to support scientific investigations involving cellular signaling, tissue-response mechanisms, extracellular matrix dynamics, and peptide interactions
Semaglutide, which is the active ingredient in Novo Nordisk's Wegovy and Ozempic, as well as tirzepatide, which is the active ingredient in Eli Lilly's Mounjaro and Zepbound, are considered GLP-1 drugs
What infection risks does the article tie to an opened semaglutide vial